Revvity stock drops about 3.5% after recently hitting a 12-month high
Revvity Inc (RVTY) declined 3.59% today after a recent 12-month high, as investors showed caution ahead of the company's upcoming third-quarter earnings release. The move contradicts the underlying bullish technical structure, with Revvity remaining above its key moving averages and strong momentum signals present.
Highlights
- Revvity stock reached a new 12-month high as the company prepares to report third-quarter earnings next month.
- The latest earnings exceeded analyst estimates, with Revvity continuing to serve pharmaceutical, biotechnology, academic, and healthcare sectors.
- Shares of Revvity last traded at $148.12, with bullish momentum indicated by technical signals and an expected range of $139.97 to $156.28 for the next five sessions.
Earnings momentum contrasts with sustained sector selling pressure
Revvity Inc, a provider of health sciences solutions, recently reached a new 12-month high and is set to release its third-quarter earnings next month. The company's most recent earnings report exceeded consensus estimates. Revvity primarily serves pharmaceutical, biotechnology, academic, and healthcare organizations with its diagnostic and research services, though price action has remained under broader selling pressure.
Strong multi-timeframe momentum amid intraday oversold signals
Revvity is trading above its 20-day ($145.12), 50-day ($130.5), and 200-day ($107.13) moving averages, highlighting sustained bullish momentum across short-, medium-, and long-term trends. The nearest resistance is at $149.54, with support at $145.12, and additional support from the Ichimoku Kijun at $143.6. Momentum indicators like MACD and ADX signal firm buying conditions, while the RSI at 66.35 and positive CCI support continued buying interest. However, the Stochastic RSI at 3.11 shows an intraday oversold condition. Bull/Bear Power is positive at 6.47, indicating buyers dominate, although there is an overbought warning. The Awesome Oscillator is currently neutral. There is a divergence between strong overall momentum and short-term oscillator readings as the stock trades near its intraday low with daily volatility at 4.29%.
Earlier, analysts noted that Revvity maintained a bullish technical setup supported by strong momentum, despite ongoing selling pressure. With new highs achieved and earnings season approaching, ongoing volatility presents an actionable opportunity for traders to monitor the $149.54 resistance and $145.12 support as potential breakout or breakdown triggers in the short term.